Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 26.23
-0.01 (-0.04%)
Sep 18, 2026, 3:04 PM CST
SHE:000513 Revenue
Livzon Pharmaceutical Group had revenue of 2.13B CNY in the quarter ending June 30, 2026, a decrease of -31.14%. This brings the company's revenue in the last twelve months to 10.75B, down -8.93% year-over-year. In the year 2025, Livzon Pharmaceutical Group had annual revenue of 12.02B with 1.76% growth.
Revenue (ttm)
10.75B
Revenue Growth
-8.93%
P/S Ratio
1.92
Revenue / Employee
1.21M
Employees
8,878
Market Cap
20.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.02B | 208.01M | 1.76% |
| Dec 31, 2024 | 11.81B | -617.70M | -4.97% |
| Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
| Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
| Jan 1, 2022 | 12.06B | 1.54B | 14.67% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsLivzon Pharmaceutical Group News
- 4 weeks ago - Livzon Pharmaceutical Group Quarterly report: Q2 2026 - Filings
- 5 months ago - Livzon Pharmaceutical Group Quarterly report: Q1 2026 - Filings
- 6 months ago - Livzon Pharmaceutical Group Annual report: Q4 2025 - Filings
- 11 months ago - Livzon Pharmaceutical Group Quarterly report: Q3 2025 - Filings